These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2043273)

  • 1. Scopolamine- and morphine-induced impairments of spontaneous alternation performance in mice: reversal with glucose and with cholinergic and adrenergic agonists.
    Stone WS; Walser B; Gold SD; Gold PE
    Behav Neurosci; 1991 Apr; 105(2):264-71. PubMed ID: 2043273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scopolamine-induced deficits in spontaneous alternation performance: attenuation with lateral ventricle injections of glucose.
    Parsons MW; Gold PE
    Behav Neural Biol; 1992 Jan; 57(1):90-2. PubMed ID: 1567337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose and physostigmine effects on morphine- and amphetamine-induced increases in locomotor activity in mice.
    Stone WS; Rudd RJ; Gold PE
    Behav Neural Biol; 1990 Sep; 54(2):146-55. PubMed ID: 2173542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose does not reverse impairments on spontaneous alternation induced by the noncompetitive NMDA antagonist MK-801.
    Lennartz RC; Gold PE
    Neurobiol Learn Mem; 1995 Jan; 63(1):107-110. PubMed ID: 7663876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between scopolamine and muscarinic cholinergic agonists or cholinesterase inhibitors on spatial alternation performance in rats.
    Shannon HE; Bemis KG; Hendrix JC; Ward JS
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1071-7. PubMed ID: 2262893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholinergic drug effects on a delayed conditional discrimination task in the rat.
    Herremans AH; Hijzen TH; Olivier B; Slangen JL
    Behav Neurosci; 1995 Jun; 109(3):426-35. PubMed ID: 7662153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naloxone modulates the behavioral effects of cholinergic agonists and antagonists.
    Walker DL; McGlynn T; Grey C; Ragozzino M; Gold PE
    Psychopharmacology (Berl); 1991; 105(1):57-62. PubMed ID: 1745712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity to cholinergic drug treatments of aged rats with variable degrees of spatial memory impairment.
    Stemmelin J; Cassel JC; Will B; Kelche C
    Behav Brain Res; 1999 Jan; 98(1):53-66. PubMed ID: 10210522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of scopolamine on performance of rats in a delayed-response radial maze task.
    Bolhuis JJ; Strijkstra AM; Kramers RJ
    Physiol Behav; 1988; 43(4):403-9. PubMed ID: 3194458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retention enhancement by pre-test beta-endorphin and oxotremorine and its reversal by scopolamine.
    Brioni JD; Izquierdo I
    Behav Neural Biol; 1988 Nov; 50(3):251-4. PubMed ID: 2849408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence against a specific effect of cholinergic drugs on spatial memory in primates.
    Rupniak NM; Samson NA; Tye SJ; Field MJ; Iversen SD
    Behav Brain Res; 1991 Apr; 43(1):1-6. PubMed ID: 1859616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scopolamine does not disrupt spatial working memory in rats.
    Godding PR; Rush JR; Beatty WW
    Pharmacol Biochem Behav; 1982 Jun; 16(6):919-23. PubMed ID: 7111351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of morphine-induced memory impairment in mice by withdrawal in Morris water maze: possible involvement of cholinergic system.
    Li Z; Wu CF; Pei G; Xu NJ
    Pharmacol Biochem Behav; 2001 Mar; 68(3):507-13. PubMed ID: 11325406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed matching-to-sample performance by rats in a new avoidance-motivated maze: response to scopolamine and fimbria-fornix lesions.
    Bresnahan EL; Wiser PR; Muth NJ; Ingram DK
    Physiol Behav; 1992 Apr; 51(4):735-46. PubMed ID: 1594672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Memory-modulatory effects of centrally acting noradrenergic drugs: possible involvement of brain cholinergic mechanisms.
    Introini-Collison IB; Baratti CM
    Behav Neural Biol; 1992 May; 57(3):248-55. PubMed ID: 1319706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholinergic modulation of spatial working memory of mice in radial maze performance: retention curve analysis.
    Inagawa K
    Yakubutsu Seishin Kodo; 1993 Aug; 13(4):233-8. PubMed ID: 8237140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of cholinergic blockade on performance of rats in the water tank navigation task and in a radial water maze.
    Buresová O; Bolhuis JJ; Bures J
    Behav Neurosci; 1986 Aug; 100(4):476-82. PubMed ID: 3741599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of morphine-induced behavioral changes in rodents by D- and L-glucose.
    Talley CP; Arankowsky-Sandoval G; McCarty R; Gold PE
    Neurobiol Learn Mem; 1999 Jan; 71(1):62-79. PubMed ID: 9889073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time gradient for post-test vulnerability to scopolamine-induced amnesia following the initial acquisition session of a spatial reference memory task in mice.
    Toumane A; Durkin TP
    Behav Neural Biol; 1993 Sep; 60(2):139-51. PubMed ID: 8117239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the effects of scopolamine on the habituation of exploratory activity: differential effects of oxotremorine and physostigmine.
    Ukai M; Kobayashi T; Kameyama T
    Gen Pharmacol; 1994 May; 25(3):433-8. PubMed ID: 7926587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.